Showing results (21-30 of 98) with videos related to
Sort By:
Pageof 10
European Journal of Biochemistry|November 19, 2003
Identification of CD4 and transferrin receptor antibodies by CXCR4 antibody-guided Pathfinder selectionJianhua Sui, Jirong Bai, Aimee St Clair Tallarico, et al.Journal of Molecular Biology|April 25, 2006
Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptidesNatalia Tarnovitski, Leslie J Matthews, Jianhua Sui, et al.Plos Pathogens|May 3, 2014
Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A virusesYuval Avnir, Aimee S Tallarico, Quan Zhu, et al.Protein Engineering, Design & Selection : PEDS|October 22, 2015
Reconstitution of the receptor-binding motif of the SARS coronavirusNatalia T Freund, Anna Roitburd-Berman, Jianhua Sui, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 16, 2020
High-Throughput Image Cytometry Detection Method for CAR-T Transduction, Cell Proliferation, and Cytotoxicity AssaysYufei Wang, Leo Li-Ying Chan, Marion Grimaud, et al.Immunology|November 3, 2011
Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5+ B cellsSubhabrata Biswas, Hong Chang, Phuong T N Sarkis, et al.Journal of Molecular Biology|December 9, 2003
Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivationFrancesca Gennari, Smita Mehta, Yang Wang, et al.Immuno-Oncology Insights|May 3, 2023
Preclinical models for development of immune-oncology therapiesYufei Wang, Sarah E Shelton, Gabriella Kastrunes, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
Optimization of ex vivo activation and expansion of macaque primary CD4-enriched peripheral blood mononuclear cells for use in anti-HIV immunotherapy and gene therapy strategiesDongsheng Zhang, Akikazu Murakami, R Paul Johnson, et al.Pathogens (Basel, Switzerland)|January 25, 2025
Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent CohortJared Sheehan, Amber J Trauth, Michael E Hagensee, et al.Pageof 10